Xellia (Taizhou) Pharmaceuticals Co., Ltd.
Drug manufacturer · Taizhou, China
Xellia (Taizhou) Pharmaceuticals Co., Ltd., based in Taizhou, China, has 1 FDA inspection on file.
FDA record
Recent FDA actions
Questions about Xellia (Taizhou) Pharmaceuticals Co., Ltd
No warning letter naming Xellia (Taizhou) Pharmaceuticals Co., Ltd is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Xellia (Taizhou) Pharmaceuticals Co., Ltd. The latest inspection ended on 2026-07-03 and was classified NAI (no action indicated). FDA posts a classification after its review, often months after the inspection ended.
Xellia (Taizhou) Pharmaceuticals Co., Ltd is based in Taizhou, China. The address is the one on its FDA records, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Xellia (Taizhou) Pharmaceuticals Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Xellia (Taizhou) Pharmaceuticals Co., Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.